Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionBlair William & Co/il
Latest Disclosed Ownership25,690 shares
Latest Disclosed Value $ 559,014
Blair William & Co/il ownership in SRPT / Sarepta Therapeutics, Inc.

On May 8, 2026 - Blair William & Co/il filed a 13F-HR form disclosing ownership of 25,690 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $559,014 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 26,333 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of -2.44% during the quarter.

Blair William & Co/il has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 25,690 -643 -2.44 559 -1.24 0.0016
2026-02-17 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 26,333 -7,299 -21.70 567 -12.65 0.0015
2025-11-12 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 33,632 6,459 23.77 648 39.66 0.0017
2025-07-24 2025-06-30 13F SAREPTA THERAPEUTICS COM 803607100 27,173 -16,942 -38.40 465 -83.52 0.0013
2025-05-09 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 44,115 -362 -0.81 2,815 -47.94 0.0085
2025-02-12 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 44,477 -4,685 -9.53 5,408 -11.92 0.0157
2024-11-12 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 49,162 -125,120 -71.79 6,140 -77.71 0.0180
2024-08-12 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 174,282 131,112 303.71 27,537 392.77 0.0849
2024-05-09 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 43,170 -1,197 -2.70 5,589 30.62 0.0176
2024-02-12 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 44,367 -11,998 -21.29 4,278 -37.38 0.0146
2023-11-09 2023-09-30 13F SAREPTA THERAPEUTICS COM 803607100 56,365 9,370 19.94 6,833 26.97 0.0262
2023-08-11 2023-06-30 13F SAREPTA THERAPEUTICS COM 803607100 46,995 25,983 123.66 5,382 85.81 0.0197
2023-05-12 2023-03-31 13F SAREPTA THERAPEUTICS COM 803607100 21,012 -711 -3.27 2,896 2.91 0.0116
2023-02-10 2022-12-31 13F SAREPTA THERAPEUTICS COM 803607100 21,723 630 2.99 2,815 20.67 0.0122
2022-11-09 2022-09-30 13F SAREPTA THERAPEUTICS COM 803607100 21,093 -1,020 -4.61 2,332 40.65 0.0107
2022-08-10 2022-06-30 13F SAREPTA THERAPEUTICS COM 803607100 22,113 -8,458 -27.67 1,658 -30.57 0.0074
2022-05-13 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 30,571 -6,325 -17.14 2,388 -28.12 0.0084
2022-02-14 2021-12-31 13F SAREPTA THERAPEUTICS COM 803607100 36,896 -1,903 -4.90 3,322 -7.41 0.0104
2021-11-12 2021-09-30 13F SAREPTA THERAPEUTICS COM 803607100 38,799 4,401 12.79 3,588 34.18 0.0122
2021-08-12 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 34,398 1,488 4.52 2,674 9.01 0.0093
2021-05-13 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 32,910 -16,654 -33.60 2,453 -70.97 0.0093
2021-02-09 2020-12-31 13F SAREPTA THERAPEUTICS COM 803607100 49,564 1,995 4.19 8,450 26.50 0.0310
2020-11-06 2020-09-30 13F SAREPTA THERAPEUTICS COM 803607100 47,569 2,746 6.13 6,680 -7.05 0.0283
2020-08-12 2020-06-30 13F SAREPTA THERAPEUTICS COM 803607100 44,823 5,854 15.02 7,187 88.54 0.0343
2020-05-11 2020-03-31 13F SAREPTA THERAPEUTICS COM 803607100 38,969 10,383 36.32 3,812 3.33 0.0238
2020-02-13 2019-12-31 13F SAREPTA THERAPEUTICS COM 803607100 28,586 1,790 6.68 3,689 82.80 0.0190
2019-11-12 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 26,796 1,423 5.61 2,018 -47.65 0.0116
2019-08-13 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 25,373 6,230 32.54 3,855 68.93 0.0220
2019-05-14 2019-03-31 13F SAREPTA THERAPEUTICS COM 803607100 19,143 -4,347 -18.51 2,282 -10.96 0.0139
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS COM 803607100 23,490 -6,085 -20.57 2,563 -46.35 0.0187
2018-11-13 2018-09-30 13F SAREPTA THERAPEUTICS COM 803607100 29,575 -445 -1.48 4,777 20.39 0.0293
2018-08-13 2018-06-30 13F SAREPTA THERAPEUTICS COM 803607100 30,020 -3,555 -10.59 3,968 59.49 0.0270
2018-05-15 2018-03-31 13F SAREPTA THERAPEUTICS COM 803607100 33,575 -11,435 -25.41 2,488 -0.64 0.0176
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM 803607100 45,010 775 1.75 2,504 24.83 0.0170
2017-11-13 2017-09-30 13F SAREPTA THERAPEUTICS COM 803607100 44,235 27,210 159.82 2,006 249.48 0.0150
2017-08-04 2017-06-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 17,025 17,025 574 0.0043
2015-08-03 2015-06-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 0 -10,100 -100.00 0 -100.00
2015-05-11 2015-03-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 10,100 -4,182 -29.28 134 -80.12 0.0002
2013-11-12 2013-09-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 14,282 7,907 124.03 674 178.51 0.0012
2013-08-07 2013-06-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 6,375 6,375 242 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-08-13 2018-06-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F SAREPTA THERAPEUTICS COM Call 100 0.00 7 16.67 n/a n/a n/a
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM Call 100 6 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.